{"id":"https://openalex.org/W2147147339","doi":"https://doi.org/10.1517/14656566.2014.960842","title":"A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine","display_name":"A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine","alternate_titles":[],"publication_year":2014,"publication_date":"2014-09-16","ids":{"openalex":"https://openalex.org/W2147147339","doi":"https://doi.org/10.1517/14656566.2014.960842","mag":"2147147339","pmid":"https://pubmed.ncbi.nlm.nih.gov/25224953"},"language":"en","primary_location":{"id":"doi:10.1517/14656566.2014.960842","doi":"https://doi.org/10.1517/14656566.2014.960842","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656566.2014.960842","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2147147339"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052893558","display_name":"William James Deardorff","orcid":"https://orcid.org/0000-0002-7947-3008","observed_orcids":["https://orcid.org/0000-0002-7947-3008"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William James Deardorff","raw_affiliation_strings":["St. Louis University School of Medicine, USA","St. Louis University School of Medicine, 1438 South Grand St Louis, MO 63104, USA +1 314 977 4829"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Louis University School of Medicine, USA","institution_ids":["https://openalex.org/I47838141"]},{"raw_affiliation_string":"St. Louis University School of Medicine, 1438 South Grand St Louis, MO 63104, USA +1 314 977 4829","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008190526","display_name":"George Thomas Grossberg","orcid":"https://orcid.org/0000-0002-1493-3931","observed_orcids":["https://orcid.org/0000-0002-1493-3931"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George T Grossberg","raw_affiliation_strings":["St. Louis University School of Medicine, USA","St. Louis University School of Medicine, 1438 South Grand St Louis, MO 63104, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Louis University School of Medicine, USA","institution_ids":["https://openalex.org/I47838141"]},{"raw_affiliation_string":"St. Louis University School of Medicine, 1438 South Grand St Louis, MO 63104, USA","institution_ids":["https://openalex.org/I47838141"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I47838141"],"apc_list":null,"apc_paid":null,"fwci":0.8037,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.57381616,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"15","issue":"17","first_page":"2525","last_page":"2542"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vilazodone","display_name":"vilazodone","score":0.9309999942779541},{"id":"https://openalex.org/keywords/levomilnacipran","display_name":"levomilnacipran","score":1.0},{"id":"https://openalex.org/keywords/vortioxetine","display_name":"vortioxetine","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9679999947547913},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.8849999904632568},{"id":"https://openalex.org/keywords/serotonin-transporter-inhibition","display_name":"serotonin transporter inhibition","score":0.7590000033378601},{"id":"https://openalex.org/keywords/norepinephrine-transporter","display_name":"norepinephrine transporter","score":0.8629999756813049},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.5009999871253967},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.9100000262260437},{"id":"https://openalex.org/keywords/sexual-side-effects","display_name":"sexual side effects","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cognitive-enhancement","display_name":"cognitive enhancement","score":0.7599999904632568},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8349999785423279},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C2778034309","wikidata":"https://www.wikidata.org/wiki/Q3563148","display_name":"Vortioxetine","level":4,"score":0.9703978300094604},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8129984140396118},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7549843192100525},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6975815296173096},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.6707327365875244},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5745800733566284},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4521968960762024},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4358358681201935},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39928314089775085},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.1689165234565735},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.04954919219017029}],"mesh":[{"descriptor_ui":"D000069503","descriptor_name":"Vilazodone Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078764","descriptor_name":"Milnacipran","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078784","descriptor_name":"Vortioxetine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/14656566.2014.960842","doi":"https://doi.org/10.1517/14656566.2014.960842","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656566.2014.960842","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:25224953","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25224953","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":90,"referenced_works":["https://openalex.org/W108869947","https://openalex.org/W181499380","https://openalex.org/W205177782","https://openalex.org/W296622129","https://openalex.org/W845297282","https://openalex.org/W1570504112","https://openalex.org/W1781131011","https://openalex.org/W1847362570","https://openalex.org/W1919874151","https://openalex.org/W1965655537","https://openalex.org/W1966819687","https://openalex.org/W1968912840","https://openalex.org/W1970755410","https://openalex.org/W1971568036","https://openalex.org/W1975918707","https://openalex.org/W1980544360","https://openalex.org/W1983176528","https://openalex.org/W1987514922","https://openalex.org/W1987560991","https://openalex.org/W1990488797","https://openalex.org/W1991923023","https://openalex.org/W1992574890","https://openalex.org/W1995370693","https://openalex.org/W1995472991","https://openalex.org/W2000247455","https://openalex.org/W2001014758","https://openalex.org/W2001782289","https://openalex.org/W2005648100","https://openalex.org/W2008565107","https://openalex.org/W2011229282","https://openalex.org/W2011606125","https://openalex.org/W2012424074","https://openalex.org/W2018273325","https://openalex.org/W2025491005","https://openalex.org/W2028195884","https://openalex.org/W2029732660","https://openalex.org/W2032301863","https://openalex.org/W2032335884","https://openalex.org/W2034822819","https://openalex.org/W2036812642","https://openalex.org/W2037304868","https://openalex.org/W2046440231","https://openalex.org/W2048026164","https://openalex.org/W2051198709","https://openalex.org/W2054766240","https://openalex.org/W2054931962","https://openalex.org/W2056356983","https://openalex.org/W2056557265","https://openalex.org/W2059274457","https://openalex.org/W2061669920","https://openalex.org/W2061731424","https://openalex.org/W2066283885","https://openalex.org/W2070787449","https://openalex.org/W2071338229","https://openalex.org/W2071735605","https://openalex.org/W2072080423","https://openalex.org/W2073570537","https://openalex.org/W2075743517","https://openalex.org/W2077845063","https://openalex.org/W2078647070","https://openalex.org/W2078790138","https://openalex.org/W2085758661","https://openalex.org/W2088736589","https://openalex.org/W2089750293","https://openalex.org/W2091733995","https://openalex.org/W2098561662","https://openalex.org/W2102298517","https://openalex.org/W2103009004","https://openalex.org/W2107031757","https://openalex.org/W2109860355","https://openalex.org/W2114821213","https://openalex.org/W2115905656","https://openalex.org/W2116153150","https://openalex.org/W2118984041","https://openalex.org/W2132577167","https://openalex.org/W2132699864","https://openalex.org/W2133308299","https://openalex.org/W2134918392","https://openalex.org/W2137296158","https://openalex.org/W2141083688","https://openalex.org/W2143049395","https://openalex.org/W2146659162","https://openalex.org/W2150656793","https://openalex.org/W2151592453","https://openalex.org/W2153644230","https://openalex.org/W2320835405","https://openalex.org/W2321037093","https://openalex.org/W4300870773","https://openalex.org/W7000691314","https://openalex.org/W7135897087"],"related_works":["https://openalex.org/W1052377954","https://openalex.org/W2765793182","https://openalex.org/W2769831433","https://openalex.org/W2303248055","https://openalex.org/W2313305389","https://openalex.org/W4308105781","https://openalex.org/W2312255064","https://openalex.org/W1943680688","https://openalex.org/W2769781658","https://openalex.org/W2804332108"],"abstract_inverted_index":{"INTRODUCTION:":[0],"As":[1],"a":[2,70,146,213],"leading":[3],"cause":[4],"of":[5,16,51,72,85,108,129,184,205],"disability,":[6],"major":[7],"depressive":[8,207],"disorder":[9],"(MDD)":[10],"is":[11,47,138,179],"characterized":[12],"by":[13,30],"reduced":[14],"quality":[15],"life":[17],"and":[18,33,95,106,150,175],"altered":[19],"functioning.":[20,177],"Current":[21],"pharmaceutical":[22],"treatment":[23,84,128],"options":[24],"are":[25,124,202],"limited":[26],"in":[27,44,88,92,97,126,168,190,217],"their":[28],"success":[29],"modest":[31],"effects":[32,155],"adverse":[34],"events":[35],"that":[36],"often":[37],"lead":[38],"to":[39,48,135,144,165,196],"discontinuation.":[40],"One":[41],"current":[42],"trend":[43],"antidepressant":[45,218],"development":[46],"combine":[49],"inhibition":[50],"the":[52,60,76,83,103,114,127,181,185],"serotonin":[53,65],"transporter":[54,62],"with":[55,187],"other":[56,136],"pharmacological":[57],"targets,":[58],"including":[59,172],"norepinephrine":[61],"or":[63],"different":[64],"receptors.":[66],"AREAS":[67],"COVERED:":[68],"In":[69],"span":[71],"<":[73],"3":[74],"years,":[75],"FDA":[77],"approved":[78],"three":[79,110,122,186],"new":[80],"antidepressants":[81,137],"for":[82],"MDD:":[86],"vilazodone":[87],"January":[89],"2011,":[90],"levomilnacipran":[91],"July":[93],"2013":[94],"vortioxetine":[96],"September":[98],"2013.":[99],"This":[100],"article":[101],"reviews":[102],"efficacy,":[104],"safety":[105],"tolerability":[107],"these":[109,210],"drugs":[111,123,211],"mainly":[112],"from":[113],"Phase":[115],"III":[116],"trial":[117],"data.":[118],"EXPERT":[119],"OPINION:":[120],"All":[121],"effective":[125,167],"MDD,":[130],"but":[131,156],"data":[132],"comparing":[133],"them":[134],"currently":[139,180],"lacking.":[140],"Vilazodone":[141],"was":[142],"proposed":[143],"produce":[145],"more":[147],"rapid":[148],"onset":[149],"have":[151,197],"fewer":[152],"sexual":[153],"side":[154],"neither":[157],"effect":[158],"has":[159],"been":[160],"conclusively":[161],"shown.":[162],"Levomilnacipran":[163],"appears":[164,195],"be":[166],"improving":[169],"functional":[170],"impairment,":[171],"both":[173],"social":[174],"work":[176],"Vortioxetine":[178],"only":[182],"drug":[183,219],"proven":[188],"efficacy":[189],"elderly":[191],"patients.":[192],"It":[193],"also":[194],"cognitive":[198],"enhancing":[199],"properties":[200],"which":[201],"largely":[203],"independent":[204],"improved":[206],"symptoms.":[208],"Overall,":[209],"represent":[212],"promising":[214],"step":[215],"forward":[216],"development.":[220]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2147147339","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
